Weiss Multi Strategy Advisers LLC Obs Eva Sa Transaction History

Weiss Multi Strategy Advisers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.48 - $8.1 $59,520 - $194,400	-24,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.22 - $11.2 $8,220 - $11,200	1,000 Added 4.35%	24,000 $200,000
Q1 2019 May 15, 2019	BUY	$11.82 - $14.48 $23,640 - $28,960	2,000 Added 9.52%	23,000 $294,000
Q4 2018 Feb 14, 2019	BUY	$10.8 - $17.94 $9,774 - $16,235	905 Added 4.5%	21,000 $266,000
Q3 2018 Nov 14, 2018	BUY	$10.92 - $18.18 $1,037 - $1,727	95 Added 0.48%	20,095 $362,000
Q1 2018 May 15, 2018	BUY	$9.36 - $15.22 $187,200 - $304,400	20,000 New	20,000 $270,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.